1. Home
  2. INCR

as of 12-23-2025 4:00pm EST

$1.18
$0.05
-4.07%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Chart Type:
Time Range:
Founded: 1994 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 79.3M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 46.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.42 EPS Growth: N/A
52 Week Low/High: $1.22 - $1.79 Next Earning Date: 10-08-2025
Revenue: $72,158,312 Revenue Growth: -10.84%
Revenue Growth (this year): 69.54% Revenue Growth (next year): 41.75%

AI-Powered INCR Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 72.30%
72.30%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: